EUVIMED · CrossrefJournal
Cancer Nanotechnology
ISSN 1868-6958 · Springer Science and Business Media LLC
Latest articles
Quercetin-Fe nanodots inhibit cervical cancer cell proliferation by targeting PCNA
Smart DNA hydrogels for post-surgical hemostasis and tumor recurrence prevention: bridging bioengineering and clinical translation
Advance of nanobody drug conjugates (NDCs) for cancer therapy
Precision oncology with nanozymes: multifunctional platforms for targeted tumor treatment
Nanotechnology in oral cancer: a theranostic approach for diagnosis, targeted therapy, and clinical translation
Translational progress of stimulus-responsive smart nanocarrier platforms for cancer theranostics: a review
Metal–organic framework-based therapeutic strategies for hepatocellular carcinoma: current advances and future perspectives
Tumor-targeted nanobubbles delivering PFP/siFGFR1 for US imaging and overcoming enzalutamide-resistant in prostate cancer
Improved anticancer efficacy of cisplatin co-delivered with nisin-decorated solid lipid nanoparticles
The role of platelet-derived microparticles in the progression of acute myeloid leukemia and their application in cancer nanotechnology
Docetaxel-loaded pH/ROS dual-responsive nanoparticles for the targeted treatment of gastric cancer
Enhanced anticancer efficacy of oxaliplatin-loaded PEGylated niosomes in breast cancer treatment
Updates and current states on liposomal vehicles for tumor targeting: precision therapy in the spotlight
PEG-functionalized UiO-66 MOFs for targeted vincristine delivery: enhanced cytotoxicity in breast and ovarian cancer cell lines
Modulatory effects of bisdemethoxycurcumin-conjugated silver/selenium nanoparticles on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis
Artemisinin-loaded polylactic acid nanoparticles alleviate 1.2 N,N-dimethylhydrazine-induced colorectal cancer in Albino rats
In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we?
Engineered exosomes: advanced nanocarriers for targeted therapy and drug delivery in hematological malignancies
β-cyclodextrin-based multifunctional carriers for colon-targeted drug delivery: advances in hydrogel systems and mucoadhesive strategies
Nanodrug-based modulation of platelet–leukocyte interactions in ovarian cancer: a new frontier in targeted therapy
Regulation of oxidative stress and inflammation caused by drug accumulation in the TME based on EPR-passive strategy and active targeting
Nanocarrier-mediated photothermal therapy and its combined strategies: mechanism exploration and application in tumour treatment
A nano-cocktail of the PARP inhibitor talazoparib and CDK inhibitor dinaciclib for the treatment of triple negative breast cancer
Dual-targeting nanomedicine achieves synergistic multimodal therapy for tumor
Investigation of mitochondria-dependent apoptosis pathway and lipid peroxidation level induced by biosynthesized silver nanoparticles: caspase-3 activation, BAK1/BCLx regulation and malondialdehyde production
Optimization and characterization of quercetin-loaded solid lipid nanoparticles for biomedical application in colorectal cancer
Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics
Mild hyperthermia via gold nanoparticles and visible light irradiation for enhanced siRNA and ASO delivery in 2D and 3D tumour spheroids
Advancing colorectal cancer therapy with biosynthesized cobalt oxide nanoparticles: a study on their antioxidant, antibacterial, and anticancer efficacy
As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy
EUVIMED